Navigation Links
Anadys Pharmaceuticals to Report First Quarter 2011 Financial Results
Date:5/2/2011

SAN DIEGO, May 2, 2011 /PRNewswire/ -- Anadys Pharmaceuticals, Inc. (Nasdaq: ANDS) announced today that it will report first quarter 2011 financial results on Thursday, May 5, 2011, after the U.S. financial markets close.

Anadys will hold a conference call and webcast on Thursday, May 5, 2011 at 5:00 p.m. Eastern Daylight Time to discuss its first quarter 2011 financial results and highlights and to provide an update on its development programs.  A live webcast of the call will be available online at www.anadyspharma.com.  A telephone replay will also be available approximately one hour after completion of the call.  To access the telephone replay, dial 888-286-8010 (domestic) or 617-801-6888 (international), passcode 23621944.  The webcast and telephone replay will be available through May 19, 2011.

About Anadys

Anadys Pharmaceuticals, Inc. is a biopharmaceutical company dedicated to improving patient care by developing novel medicines for the treatment of hepatitis C.  The Company believes hepatitis C represents a large unmet medical need in which meaningful improvements in treatment outcomes may be attainable with the introduction of new medicines.  Anadys is conducting a Phase IIb study of ANA598, the Company's direct-acting antiviral or DAA, added to current standard of care for the treatment of hepatitis C.  The Company is also preparing to resume clinical development of ANA773, the Company's oral, small-molecule inducer of endogenous interferons that acts via the Toll like receptor 7, or TLR7, pathway in hepatitis C.

Safe Harbor Statement

Statements in this press release that are not strictly historical in nature constitute "forward-looking statements."  Such statements include, but are not limited to, references to Anadys' strategy, development
'/>"/>

SOURCE Anadys Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Anadys Pharmaceuticals Reports Fourth Quarter and Year-End 2010 Financial Results and Highlights
2. Anadys Pharmaceuticals Augments Management Team and Board of Directors
3. Anadys Pharmaceuticals to Present at the Lazard Healthcare Conference
4. Anadys Pharmaceuticals to Report Fourth Quarter and Year End 2009 Financial Results
5. Anadys Pharmaceuticals Receives FDA Clearance of Phase II Protocol to Study ANA598 in Combination With Interferon-Alpha and Ribavirin in HCV Patients
6. Anadys Pharmaceuticals Reports Second Quarter 2009 Financial Results and Program Highlights
7. Anadys Pharmaceuticals to Report Second Quarter 2009 Financial Results
8. Anadys Pharmaceuticals, Inc. Announces Strategic Restructuring to Focus Operations on Continuing the Advancement of ANA598
9. Anadys Pharmaceuticals Reports First Quarter 2009 Financial Results and Highlights
10. Anadys Pharmaceuticals to Report First Quarter 2009 Financial Results
11. Anadys Pharmaceuticals to Present at Future Leaders in the Biotech Industry
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... BioTrends Research Group, one of the ... biopharmaceutical issues, finds that, unaided, one in five ... that in the past six months, they have ... anticipation of the next generation of HCV treatments—notably ... 6 percent reported that they had begun warehousing ...
(Date:5/23/2013)... -- Z Trim Holdings, Inc. (OTC Markets: ZTHO), a ... industries, announced that Chef Erin Ryan ... National Restaurant Association ("NRA") NRA Show, which was held ... Chefs Association.  Chef Ryan spoke on the subject of ... the Ugly," joining four other prestigious panelists including:  Kit ...
(Date:5/23/2013)... 23, 2013 The New Jersey chapter ... Black Data Processing Associates (BDPA), is hosting its 10th ... 2013. This all-day event will encourage students and their ... ins and outs from many of the industries’ finest ... the New Jersey Institute of Technology, the event will ...
(Date:5/23/2013)... , May 23, 2013  Verenium Corporation (Nasdaq: ... on the development and commercialization of high-performance enzymes, today ... Financial Officer, will present at two upcoming conferences. ... will present at the Second Annual Marcum LLP Microcap ... Hyatt Hotel in New York City.  The presentation is ...
Breaking Biology Technology:The Majority of Physicians that Treat Hepatitis C Virus (HCV) Have Begun "Warehousing" and Preparing Their HCV Patients for the Next Generation of HCV Treatments 2The Majority of Physicians that Treat Hepatitis C Virus (HCV) Have Begun "Warehousing" and Preparing Their HCV Patients for the Next Generation of HCV Treatments 3Z Trim's Chef Erin Ryan sits on Expert Panel at NRA Show 2Z Trim's Chef Erin Ryan sits on Expert Panel at NRA Show 3Black Data Processing Associates (BDPA) New Jersey Hosts 10th Annual Families in Technology Day June 8, 2013 2Verenium To Present At Two Upcoming Conferences 2Verenium To Present At Two Upcoming Conferences 3
... SAN DIEGO, Feb. 15, 2011 Ceregene, ... and collaborators have published new experimental findings in support ... lead article in the current issue of Movement Disorders ... publication reports the first evidence that gene transfer can ...
... has just launched the first European repository of ... types of reference nanomaterials. This will support safety ... many innovative applications and products. Nanotechnology is one ... a harmonised risk assessment the repository can contribute ...
... RESEARCH TRIANGLE PARK, N.C., Feb. 14, 2011 ... 59th annual Neurological Society of India & Congress ... this past December.  The event was a convergence ... and researchers from across the globe to discuss ...
Cached Biology Technology:Ceregene Reports New Findings Regarding How Parkinson's Brains Respond to Neurotrophic Factors 2Ceregene Reports New Findings Regarding How Parkinson's Brains Respond to Neurotrophic Factors 3Ceregene Reports New Findings Regarding How Parkinson's Brains Respond to Neurotrophic Factors 4Ceregene Reports New Findings Regarding How Parkinson's Brains Respond to Neurotrophic Factors 5Small material, big impact 2Max Neeman International Initiates Advisory Committee to Advance and Improve the Conduct of Complex Neurological Trials in India 2
(Date:5/24/2013)... and other non-coding RNAs are small molecules that ... recent years they have emerged as disease biomarkers. ... origin for cancers of unknown primary origin, determine ... but clinically tractable, diagnostic methods for monitoring miRNA ... In this issue of the Journal of ...
(Date:5/24/2013)... 500 leading water scientists from around the world today ... the short span of one or two generations, the ... be living under the handicap of severe pressure on ... there is no substitute. This handicap will be self-inflicted ... bluntly pointed to chronic underlying problems led by mismanagement ...
(Date:5/23/2013)... National Laboratory honored more than 165 staff for ... at PNNL,s annual Intellectual Property Commercialization Recognition & ... Energy national laboratory named materials scientist Jun Liu ... battery materials that can store large amounts of ... reduce the time it takes to charge cell ...
Breaking Biology News(10 mins):A majority on Earth face severe self-inflicted water woes within 2 generations: Scientists 2A majority on Earth face severe self-inflicted water woes within 2 generations: Scientists 3A majority on Earth face severe self-inflicted water woes within 2 generations: Scientists 4PNNL staff recognized for scientific accomplishments, moving technologies into the marketplace 2
... have developed a commercially viable method for mass producing ... instead of the months required for traditional egg-based vaccines. ... Biodefense Research , The next flu pandemic could happen ... Sciences Corporation (PSC) and a researcher on the study. ...
... to someone talk and also hearing the buzz of the ... conversation down the hallway. To focus on the person speaking ... all incoming sensory information. It has to attend to what ... the Stanford University School of Medicine have taken a big ...
... Allergy and Infectious Diseases (NIAID), part of the ... enrollment into a large international HIV/AIDS trial comparing ... by levels of CD4+ cells has been stopped. ... therapy had twice the risk of disease progression ...
Cached Biology News:New influenza vaccine takes weeks to mass produce 2Stanford study of owls finds link in brain between sight and sound 2Stanford study of owls finds link in brain between sight and sound 3International HIV/AIDS trial finds continuous antiretroviral therapy superior to episodic therapy 2International HIV/AIDS trial finds continuous antiretroviral therapy superior to episodic therapy 3International HIV/AIDS trial finds continuous antiretroviral therapy superior to episodic therapy 4
Bovine Renal Artery Smooth Muscle Cells (BRASMC) (>500,000 cells)...
... is a major step forward in ... handling system - with one universal ... modules. All five single channel and ... one handle. The lightweight handle is ...
Sulfadimethoxine (CH-2027)...
alpha-N-Catenin Antibody Shipping Temperature: HOT Storage Temperature: -20C...
Biology Products: